1Life Healthcare Inc. [ONEM] stock Downgrade by Deutsche Bank analyst, price target now $12


1Life Healthcare Inc. [NASDAQ: ONEM] plunged by -$0.22 during the normal trading session on Tuesday and reaching a high of $17.01 during the day while it closed the day at $16.75. The company report on May 4, 2022 that One Medical Announces Results for First Quarter 2022.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .


First Quarter 2022 Ending Total Membership Count of 767,000, a 28% Increase Year-Over-Year. Ending Consumer and Enterprise Membership Count of 728,000 and At-Risk Membership Count of 39,000.

First Quarter 2022 Net Revenue of $254.1 Million, a 109% Increase Year-Over-Year.

1Life Healthcare Inc. stock has also gained 69.88% of its value over the past 7 days. However, ONEM stock has inclined by 97.29% in the 3 months of the year. Over the past six months meanwhile, it has gained 54.66% and lost -4.67% year-on date.

The market cap for ONEM stock reached $3.27 billion, with 193.02 million shares outstanding and 176.38 million shares in the current float. Compared to the average trading volume of 4.27M shares, ONEM reached a trading volume of 16417104 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Here’s what leading stock market gurus have to say about 1Life Healthcare Inc. [ONEM]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ONEM shares is $15.92 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ONEM stock is a recommendation set at 2.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

Deutsche Bank have made an estimate for 1Life Healthcare Inc. shares, keeping their opinion on the stock as Hold, with their previous recommendation back on July 12, 2022. While these analysts kept the previous recommendation, Evercore ISI raised their target price from $11 to $12. The new note on the price target was released on July 11, 2022, representing the official price target for 1Life Healthcare Inc. stock. Previously, the target price had yet another raise to $15, while BTIG Research analysts kept a Buy rating on ONEM stock.

The Average True Range (ATR) for 1Life Healthcare Inc. is set at 1.03, with the Price to Sales ratio for ONEM stock in the period of the last 12 months amounting to 4.32. The Price to Book ratio for the last quarter was 1.93, with the Price to Cash per share for the same quarter was set at 1.95.

ONEM stock trade performance evaluation

1Life Healthcare Inc. [ONEM] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 69.88. With this latest performance, ONEM shares gained by 83.66% in over the last four-week period, additionally plugging by 54.66% over the last 6 months – not to mention a drop of -36.96% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ONEM stock in for the last two-week period is set at 76.12, with the RSI for the last a single of trading hit 79.80, and the three-weeks RSI is set at 72.52 for 1Life Healthcare Inc. [ONEM]. The present Moving Average for the last 50 days of trading for this stock 9.44, while it was recorded at 15.66 for the last single week of trading, and 12.84 for the last 200 days.

1Life Healthcare Inc. [ONEM]: An insightful look at the core fundamentals

Operating Margin for any stock indicates how profitable investing would be, and 1Life Healthcare Inc. [ONEM] shares currently have an operating margin of -39.46 and a Gross Margin at +22.50. 1Life Healthcare Inc.’s Net Margin is presently recorded at -40.97.

Return on Equity for this stock declined to -22.37, with Return on Assets sitting at -13.16.

1Life Healthcare Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 2.60 and a Current Ratio set at 2.60.

1Life Healthcare Inc. [ONEM]: Insider Ownership positions

There are presently around $2,571 million, or 82.00% of ONEM stock, in the hands of institutional investors. The top three institutional holders of ONEM stocks are: TIGER GLOBAL MANAGEMENT LLC with ownership of 17,673,234, which is approximately 28.131% of the company’s market cap and around 0.10% of the total institutional ownership; VANGUARD GROUP INC, holding 14,448,803 shares of the stock with an approximate value of $245.2 million in ONEM stocks shares; and CARLYLE GROUP INC., currently with $231.01 million in ONEM stock with ownership of nearly 0% of the company’s market capitalization.

Positions in 1Life Healthcare Inc. stocks held by institutional investors increased at the end of August and at the time of the August reporting period, where 89 institutional holders increased their position in 1Life Healthcare Inc. [NASDAQ:ONEM] by around 24,155,581 shares. Additionally, 103 investors decreased positions by around 18,505,123 shares, while 37 investors held positions by with 108,857,750 shares. The mentioned changes placed institutional holdings at 151,518,454 shares, according to the latest SEC report filing. ONEM stock had 28 new institutional investments in for a total of 7,038,508 shares, while 39 institutional investors sold positions of 13,501,492 shares during the same period.